Clinical trials
Active, not recruiting Phase 1/2 Leukemia, Myeloid, Acute trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 23 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 4 |
| AbbVie | 2 |
| Bellicum Pharmaceuticals | 2 |
| National Cancer Institute (NCI) | 2 |
| Akeso | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Celgene | 1 |
| Center for International Blood and Marrow Transplant Research | 1 |
| City of Hope Medical Center | 1 |
| Daiichi Sankyo | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 23 |
| Myelodysplastic Syndromes | 9 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 8 |
| Leukemia | 5 |
| Hematologic Neoplasms | 4 |
| Leukemia, Myelomonocytic, Chronic | 4 |
| Anemia, Refractory, with Excess of Blasts | 3 |
| Myeloproliferative Disorders | 3 |
| Recurrence | 3 |
| Anemia, Aplastic | 2 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.